bazedoxifene has been researched along with Venous Thromboembolism in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Komm, BS; Mirkin, S; Pinkerton, JV | 1 |
Komm, BS; Mirkin, S; Thompson, JR | 1 |
Currie, H; Dragon, E; Mikkola, TS; Palacios, S | 1 |
Arnal, JF; Gourdy, P; Trémollières, F; Valera, MC | 1 |
de Villiers, TJ | 2 |
6 review(s) available for bazedoxifene and Venous Thromboembolism
Article | Year |
---|---|
Tissue selective estrogen complex combinations with bazedoxifene/conjugated estrogens as a model.
Topics: Animals; Atrophy; Estrogens, Conjugated (USP); Female; Gene Expression; Hot Flashes; Humans; Indoles; Lipid Metabolism; Osteoporosis, Postmenopausal; Quality of Life; Selective Estrogen Receptor Modulators; Sleep; Vagina; Venous Thromboembolism; Vulva | 2013 |
Cardiovascular safety of conjugated estrogens plus bazedoxifene: meta-analysis of the SMART trials.
Topics: Coronary Disease; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Incidence; Indoles; Postmenopause; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Selective Estrogen Receptor Modulators; Stroke; Venous Thromboembolism | 2015 |
Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: a practical guide.
Topics: Adult; Amenorrhea; Bone Density; Breast; Drug Therapy, Combination; Estrogens; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Progestins; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Uterine Hemorrhage; Venous Thromboembolism | 2015 |
From the Women's Health Initiative to the combination of estrogen and selective estrogen receptor modulators to avoid progestin addition.
Topics: Breast Neoplasms; Coronary Disease; Estrogen Receptor alpha; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Indoles; Menopause; Progestins; Selective Estrogen Receptor Modulators; Venous Thromboembolism; Women's Health | 2015 |
Clinical issues regarding cardiovascular disease and selective estrogen receptor modulators in postmenopausal women.
Topics: Cardiovascular Diseases; Female; Humans; Indoles; Postmenopause; Pyrrolidines; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Factors; Selective Estrogen Receptor Modulators; Stroke; Tamoxifen; Tetrahydronaphthalenes; Venous Thromboembolism | 2009 |
Bazedoxifene: a novel selective estrogen receptor modulator for postmenopausal osteoporosis.
Topics: Clinical Trials, Phase III as Topic; Endometrium; Female; Fractures, Bone; Humans; Indoles; Lipids; Mammography; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators; Ultrasonography; Venous Thromboembolism | 2010 |